This is therefore a comparing of the institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation in Intec Pharma Ltd. (NASDAQ:NTEC) and Alder BioPharmaceuticals Inc. (NASDAQ:ALDR). The two are both Biotechnology companies that compete with one another.
Table 1 demonstrates Intec Pharma Ltd. and Alder BioPharmaceuticals Inc.’s gross revenue, earnings per share (EPS) and valuation.
Table 2 demonstrates the net margins, return on equity and return on assets of Intec Pharma Ltd. and Alder BioPharmaceuticals Inc.
Intec Pharma Ltd. and Alder BioPharmaceuticals Inc. Recommendations and Ratings are available on the next table.
Competitively the average target price of Alder BioPharmaceuticals Inc. is $20.67, which is potential 71.54% upside.
Institutional and Insider Ownership
Intec Pharma Ltd. and Alder BioPharmaceuticals Inc. has shares owned by institutional investors as follows: 40.23% and 0%. 16.08%